Vismodegib for advanced basal cell carcinoma: Duration of response after vismodegib discontinuation and response to vismodegib retreatment upon disease progressionJournal of the American Academy of Dermatology · 2015

Cholestatic hepatic injury associated with vismodegib, aspirin, and naproxen use: a case study and review of vismodegib safetyAsh, Mark M.; Jolly, Puneet S. · International Journal of Dermatology · 2015

Vismodegib resistant mutations are not selected in multifocal relapses of locally advanced basal cell carcinoma after vismodegib discontinuationIghilahriz, M.; Benfodda, M.; Sharpe, H.; Soufir, N.; Mourah, S.; Dumaz, N.; Battistella, M.; Savina, A.; Bouquet, F.; Nikolaev, S.; Basset‐Seguin, N. · Journal of the European Academy of Dermatology and Venereology · 2019

Complete response is reversible upon vismodegib withdrawal and re-inducible upon vismodegib re-administration in a patient with locally advanced BCCDessinioti, Clio; Plaka, Mihaella; Dimitrakopoulou, Amerini; Stratigos, Alexander J · Journal of the European Academy of Dermatology and Venereology · 2019

CADD-06. VISMODEGIB LOADED POLYOXAZOLINE (POx) MICELLES ENHANCE EFFICACY OF VISMODEGIB AND PROLONG MICE SURVIVAL, EMPHASIZE POTENTIAL OF POx MICELLES TO IMPROVE DRUG DELIVERY TO BRAIN TUMORSHwang, Duhyeong; Lim, Chaemin; Zhao, Yuling; Liu, Hedi; Kabanov, Alexander V; Gershon, Timothy; Sokolsky-Papkov, Marina · Neuro-Oncology · 2018

VismodegibGillian M. Keating · 2012

VismodegibDlugosz, Andrzej; Agrawal, Sid; Kirkpatrick, Peter · Nature Reviews Drug Discovery · 2012

VismodegibDolomatov, Michel Y.; Zhuravleva, Nadezhda A. · Reactions Weekly · 2014

Biperiden/trihexyphenidylReactions Weekly · 1995

NitrendipineReactions Weekly · 2003

ScopolamineReactions Weekly · 2007

ScopolamineReactions Weekly · 2012

ScopolamineReactions Weekly · 2009

Centella asiaticaReactions Weekly · 2011

Daunorubicin/mitoxantroneReactions Weekly · 2007

AnthracyclinesReactions Weekly · 1991